A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 269,375 shares of FLGT stock, worth $4.65 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
269,375
Holding current value
$4.65 Million
% of portfolio
0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $5.28 Million - $6.75 Million
269,375 New
269,375 $5.85 Million
Q1 2024

May 15, 2024

SELL
$21.55 - $29.29 $1.5 Million - $2.04 Million
-69,513 Reduced 45.94%
81,800 $1.78 Million
Q4 2023

Feb 14, 2024

BUY
$23.64 - $30.27 $3.52 Million - $4.51 Million
148,913 Added 6204.71%
151,313 $4.37 Million
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $63,828 - $97,413
2,387 Added 18361.54%
2,400 $64,000
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $370 - $529
13 New
13 $0
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $552,532 - $681,876
-18,800 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$29.23 - $40.28 $4.15 Million - $5.72 Million
-142,121 Reduced 88.32%
18,800 $559,000
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $2.51 Million - $4.23 Million
-66,316 Reduced 29.18%
160,921 $6.13 Million
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $7.82 Million - $10.2 Million
163,083 Added 254.21%
227,237 $12.4 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $1.02 Million - $1.97 Million
20,454 Added 46.81%
64,154 $4 Million
Q4 2021

Feb 14, 2022

SELL
$77.3 - $105.0 $13.9 Million - $18.9 Million
-180,295 Reduced 80.49%
43,700 $4.4 Million
Q3 2021

Nov 15, 2021

BUY
$74.87 - $110.87 $16.8 Million - $24.8 Million
223,995 New
223,995 $20.1 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $523M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.